Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Cisplatin
Related studies linked through entity extraction aliases.
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Sequential Tegafur-gimeracil-oteracil Potassium Capsule (s-1) and Serplulimab Following Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
Serplulimab Plus Chemoradiotherapy for Stage III-IVA Cervical Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE3
A UGT1A1 Genotype-Directed Study of Belinostat Pharmacokinetics and Toxicity
- Status
- RECRUITING
- Phase
- PHASE2
Genomic Biomarker-guided Neoadjuvant Therapy for Prostate Cancer (SEGNO)
- Status
- RECRUITING
- Phase
- PHASE2
Precision Medicine in Patients With Unresectable CholAngiocarcinoma: RadioEmbolization and Combined Biological Therapy
- Status
- RECRUITING
- Phase
- PHASE2
Study of ZG005 in Combination With Etoposide and Cisplatin in Participants With Advanced Neuroendocrine Carcinoma.
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
The Impact of Neoadjuvant Chemotherapy on Survival Outcomes in Patients With Variant Histologies Bladder Cancer Who Underwent Radical Cystectomy
- Status
- COMPLETED
- Phase
- N/A
A Study of Nimotuzumab Plus Concurrent Chemoradiotherapy Sequential Maintenance Treatment for Cervical Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE3
Stop and go Strategy as First-line Treatment for Widely Metastatic Nasopharyngeal Carcinoma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Hypofractionated Radiochemotherapy
- Status
- RECRUITING
- Phase
- PHASE2
Adaptive De-intensified Radiotherapy Using Circulating Tumor DNA in HPV- Associated Oropharyngeal Cancer
- Status
- RECRUITING
- Phase
- PHASE2
SBRT and LDRT Combined With PD-1 Antibody and Chemotherapy in r/m Nasopharyngeal Carcinoma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Status
- RECRUITING
- Phase
- PHASE3
GAMEC-II, Risk-adapted Protocol for Relapsed Germ Cell Tumours (GCT)
- Status
- COMPLETED
- Phase
- PHASE2
The Efficacy of PIPAC and Minimally Invasive Radical Resection in High-risk Gastric Cancer Patients.
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Neoadjuvant Chemoimmunotherapy and Extrafascial Hysterectomy for IB2 Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Neoadjuvant Chemotherapy Plus Camrelizumab for FIGO Stage IB1 Cervical Cancer
- Status
- RECRUITING
- Phase
- PHASE2